Developer docs
API playgroundTry for free, no card

Search company profiles

DealForma

Full company profile

uuid0008jog

Namestring
DealForma
Legal namestring
DealForma, LLC
Websiteurl
dealforma.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

DealForma is a subscription-based SaaS platform providing curated biopharma deal intelligence to business development, licensing, and corporate development teams at pharmaceutical, biotechnology, investment banking, venture capital, and advisory firms. The company maintains a database covering thousands of biopharma companies, licensing deals, M&A transactions, venture funding rounds, drug pipelines, and drug sales figures, with all profiles and records manually curated and quality-checked by analysts on a daily basis. Source documents — including press releases, SEC-filed contracts, and regulatory filings — are attached to every record, providing provenance that general-purpose databases lack.

The platform is built around three core product modules: (1) the core DealForma database, filterable across stage, modality, therapy area, target, and territory; (2) interactive Tableau dashboards embedded directly in the platform for visualization of decades of deal and funding data; and (3) natural language search that lets users query the database conversationally rather than via complex filter interfaces. Site-licensed enterprise customers additionally gain API/data feed access to pipe DealForma data into internal systems, and all subscribers receive 20 hours per year of dedicated analyst support for custom data pulls, benchmarking, chart creation, and report building. Authentication is handled via Auth0 and subscription billing via Stripe, supporting a global direct-sales motion.

DealForma monetizes exclusively through annual SaaS subscriptions priced at a $18,000-$20,000 minimum starting price, positioning the platform below competing enterprise offerings (PitchBook, BioCentury BCIQ). The go-to-market is direct enterprise field sales with scheduled 30-minute screen-share demos as the primary conversion mechanism, supplemented by content marketing via quarterly deal trend reports, an Endpoints News editorial column, and customer testimonials from named logos including GSK, Novartis, AbbVie, JPMorgan, Nimbus Therapeutics, Flagship Pioneering, and IP Group. The company is privately held and founder-led, headquartered in San Mateo, California, with a small globally distributed team of analysts and developers.

Short descriptiontext

DealForma is a subscription SaaS platform that provides curated biopharma deal intelligence — covering licensing, M&A, venture funding, and company profiles — to business development, licensing, and corporate development teams at pharmaceutical, biotech, investment, and advisory firms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Mateo, United States
HQ citystring
San Mateo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharma deal intelligence, licensing deal database, drug pipeline data, biotech deal benchmarks, biopharma market intelligence
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Biopharma Deal Intelligence Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Annual SaaS Subscription
TypeSubscription Recurring
Description

DealForma operates on a subscription model billed annually. Subscriptions include access to the full database, interactive dashboards, natural language search, data export, and bundled analyst support hours. Annual billing cycles with automatic renewal unless cancelled. Valid invoiced payment methods including credit card, wire transfer, check, or purchase order accepted. Fee changes are communicated at least 30 days in advance.

dealforma.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Site License / Enterprise (minimum starting price)
ModelSubscriptionBilling cadenceAnnual
Notes

Minimum starting price listed at $18,000 (comparison vs PitchBook). Includes full database access, Tableau dashboards, natural language search, analyst support (20 hours/year), saved searches/alerts, unlimited data export, and source documents.

dealforma.com
2Site License / Enterprise (minimum starting price)
ModelSubscriptionBilling cadenceAnnual
Notes

Minimum starting price listed at $20,000 (comparison vs BioCentury BCIQ).

dealforma.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

DealForma is a cloud-based SaaS biopharma deal intelligence platform that provides curated, analyst-vetted data on licensing deals, M&A transactions, venture funding, company profiles, drug pipelines, and drug sales figures for biotech and pharmaceutical companies. Subscriptions include interactive Tableau dashboards, natural language search, bundled analyst support, data export, and API access for site-licensed enterprise customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Customer testimonial: completed a project in one afternoon that would previously have taken a week or a student a month
+2 more records
Product overview1 text field

DealForma is a biopharma deal intelligence platform offering a unified database with multiple integrated modules. The core product is the DealForma Core Database, which provides comprehensive coverage of licensing deals, M&A, venture funding, company profiles, drug pipelines, and drug sales figures—all updated daily by analysts. The platform integrates Interactive Tableau Dashboards for data visualization and features Natural Language Search for simplified querying. All subscriptions include Analyst Support with 20 hours per year for custom analyses and benchmarking. Additional modules include Quarterly Deal Trend Reports, Data Export Capability, Data Feed/API for enterprise customers, and Saved Searches and Alerts for deal monitoring.

Product and service2 records
1DealForma Platform
CategoryBiopharma Deal Intelligence Database
Description

The primary biopharma deal intelligence SaaS platform providing meticulously researched licensing deal financial comps, up-to-date company profiles, historic deal and pipeline data, drug sales figures, and curated reports. Data covers biotech, pharma, diagnostics, medtech, and digital health companies. Designed for business development, licensing, and corporate development professionals at biopharma companies and life sciences investors.

2Quarterly Deal Trend Reports
CategoryResearch and Advisory Content
Description

Subscription deliverables offering quarterly chart packs of deal trends across therapeutic areas and deal types, designed to be embedded directly into customer presentations. Available to subscribers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

DealForma builds its interactive data dashboards using Tableau. This is a core component of the platform's data visualization capability, embedded within the DealForma interface to allow users to customize charts by therapy area, modality, stage, and other filters.

Strategic tierSupportingTypeTechnology or Integration
Description

DealForma uses Stripe as its third-party payment processor for subscription billing. Stripe handles payment card processing and is compliant with PCI-DSS standards set by the PCI Security Standards Council.

3Google Analytics
Strategic tierSupportingTypeTechnology or Integration
Description

DealForma uses Google Analytics to monitor and analyze website traffic and usage of its service.

dealforma.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

PitchBook (owned by Morningstar) is the dominant VC, PE, and M&A deal database. It is directly comparable to DealForma for biopharma deal comps but covers many industries; DealForma explicitly positions its curation depth and lower entry price ($18K vs $40K) against PitchBook.

TypeDirect peer
Description

BCIQ is BioCentury's biopharma deal intelligence platform covering licensing, M&A, and venture financing — the closest direct competitor to DealForma. DealForma's pricing comparison page lists its minimum price at $20K vs BCIQ, indicating head-to-head competition for biopharma BD subscribers.

3Cortellis (Clarivate)
TypeBroad incumbent
Description

Cortellis provides life-sciences intelligence including deals, pipelines, and company profiles as part of Clarivate's broader portfolio. Comparable to DealForma's deal-comps and pipeline data with much broader coverage but less biopharma-specific curation.

TypeDirect peer
Description

Evaluate Pharma provides consensus forecasts, deal data, and commercial intelligence for the pharma and biotech sector. It directly overlaps DealForma's drug sales figures and company profile offerings, targeting similar enterprise pharma BD users.

TypeBroad incumbent
Description

GlobalData offers deal databases, company profiles, and market intelligence across pharma and other industries. Comparable as a multi-industry incumbent that competes for similar BD intelligence budgets at large pharma.

TypeBroad incumbent
Description

CB Insights provides market intelligence on venture financing, M&A, and emerging technology trends, with coverage that overlaps DealForma's funding-rounds and company-profiles data for biopharma and adjacent verticals.

TypeEmerging player
Description

AlphaSense is a market intelligence platform aggregating broker research, SEC filings, and transcripts for enterprise research workflows. It is listed alongside DealForma among top pharma market intelligence platforms and competes for similar enterprise research budgets with an AI-first search product.

8Crunchbase
TypeBroad incumbent
Description

Crunchbase is a broad startup and investment database covering funding rounds, M&A, and company information. It overlaps DealForma's venture-funding and company-profile data, particularly for biotech and digital health startups, though with less biopharma-specific curation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DealForma

Biopharma Deal Intelligence Softwaredealforma.com

DealForma is a subscription SaaS platform that provides curated biopharma deal intelligence — covering licensing, M&A, venture funding, and company profiles — to business development, licensing, and corporate development teams at pharmaceutical, biotech, investment, and advisory firms.

What DealForma does

DealForma is a subscription-based SaaS platform providing curated biopharma deal intelligence to business development, licensing, and corporate development teams at pharmaceutical, biotechnology, investment banking, venture capital, and advisory firms. The company maintains a database covering thousands of biopharma companies, licensing deals, M&A transactions, venture funding rounds, drug pipelines, and drug sales figures, with all profiles and records manually curated and quality-checked by analysts on a daily basis. Source documents — including press releases, SEC-filed contracts, and regulatory filings — are attached to every record, providing provenance that general-purpose databases lack.

The platform is built around three core product modules: (1) the core DealForma database, filterable across stage, modality, therapy area, target, and territory; (2) interactive Tableau dashboards embedded directly in the platform for visualization of decades of deal and funding data; and (3) natural language search that lets users query the database conversationally rather than via complex filter interfaces. Site-licensed enterprise customers additionally gain API/data feed access to pipe DealForma data into internal systems, and all subscribers receive 20 hours per year of dedicated analyst support for custom data pulls, benchmarking, chart creation, and report building. Authentication is handled via Auth0 and subscription billing via Stripe, supporting a global direct-sales motion.

DealForma monetizes exclusively through annual SaaS subscriptions priced at a $18,000-$20,000 minimum starting price, positioning the platform below competing enterprise offerings (PitchBook, BioCentury BCIQ). The go-to-market is direct enterprise field sales with scheduled 30-minute screen-share demos as the primary conversion mechanism, supplemented by content marketing via quarterly deal trend reports, an Endpoints News editorial column, and customer testimonials from named logos including GSK, Novartis, AbbVie, JPMorgan, Nimbus Therapeutics, Flagship Pioneering, and IP Group. The company is privately held and founder-led, headquartered in San Mateo, California, with a small globally distributed team of analysts and developers.

DealForma firmographics

Firmographics
Name
DealForma
Legal name
DealForma, LLC
Website
https://dealforma.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
DealForma is a subscription SaaS platform that provides curated biopharma deal intelligence — covering licensing, M&A, venture funding, and company profiles — to business development, licensing, and corporate development teams at pharmaceutical, biotech, investment, and advisory firms.
Ownership category
akta.pro rank

Where DealForma is headquartered

Location

Headquarters

HQ city
San Mateo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

DealForma business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Annual SaaS Subscription: DealForma operates on a subscription model billed annually. Subscriptions include access to the full database, interactive dashboards, natural language search, data export, and bundled analyst support hours. Annual billing cycles with automatic renewal unless cancelled. Valid invoiced payment methods including credit card, wire transfer, check, or purchase order accepted. Fee changes are communicated at least 30 days in advance.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSite License / Enterprise (minimum starting price)
SubscriptionAnnualSite License / Enterprise (minimum starting price)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

DealForma product offering

Product offering

Core offering

DealForma is a cloud-based SaaS biopharma deal intelligence platform that provides curated, analyst-vetted data on licensing deals, M&A transactions, venture funding, company profiles, drug pipelines, and drug sales figures for biotech and pharmaceutical companies. Subscriptions include interactive Tableau dashboards, natural language search, bundled analyst support, data export, and API access for site-licensed enterprise customers.

Product overview

DealForma is a biopharma deal intelligence platform offering a unified database with multiple integrated modules. The core product is the DealForma Core Database, which provides comprehensive coverage of licensing deals, M&A, venture funding, company profiles, drug pipelines, and drug sales figures—all updated daily by analysts. The platform integrates Interactive Tableau Dashboards for data visualization and features Natural Language Search for simplified querying. All subscriptions include Analyst Support with 20 hours per year for custom analyses and benchmarking. Additional modules include Quarterly Deal Trend Reports, Data Export Capability, Data Feed/API for enterprise customers, and Saved Searches and Alerts for deal monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

  • DealForma Platform The primary biopharma deal intelligence SaaS platform providing meticulously researched licensing deal financial comps, up-to-date company profiles, historic deal and pipeline data, drug sales figures, and curated reports. Data covers biotech, pharma, diagnostics, medtech, and digital health companies. Designed for business development, licensing, and corporate development professionals at biopharma companies and life sciences investors.
  • Quarterly Deal Trend Reports Subscription deliverables offering quarterly chart packs of deal trends across therapeutic areas and deal types, designed to be embedded directly into customer presentations. Available to subscribers.

Quantifiable outcome

  • Customer testimonial: completed a project in one afternoon that would previously have taken a week or a student a month
  • +2 more outcomes

Companies that use DealForma

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles4 records

DealForma technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature6 records

DealForma partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and supporting.

  • TableaucoreTechnology or IntegrationDealForma builds its interactive data dashboards using Tableau. This is a core component of the platform's data visualization capability, embedded within the DealForma interface to allow users to customize charts by therapy area, modality, stage, and other filters.
  • StripesupportingTechnology or IntegrationDealForma uses Stripe as its third-party payment processor for subscription billing. Stripe handles payment card processing and is compliant with PCI-DSS standards set by the PCI Security Standards Council.
  • Google AnalyticssupportingTechnology or IntegrationDealForma uses Google Analytics to monitor and analyze website traffic and usage of its service.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

DealForma competitors and assessment

Company assessment

Broad incumbents

  • PitchBook Data: PitchBook (owned by Morningstar) is the dominant VC, PE, and M&A deal database. It is directly comparable to DealForma for biopharma deal comps but covers many industries; DealForma explicitly positions its curation depth and lower entry price ($18K vs $40K) against PitchBook.
  • Cortellis (Clarivate): Cortellis provides life-sciences intelligence including deals, pipelines, and company profiles as part of Clarivate's broader portfolio. Comparable to DealForma's deal-comps and pipeline data with much broader coverage but less biopharma-specific curation.
  • GlobalData: GlobalData offers deal databases, company profiles, and market intelligence across pharma and other industries. Comparable as a multi-industry incumbent that competes for similar BD intelligence budgets at large pharma.
  • CB Insights: CB Insights provides market intelligence on venture financing, M&A, and emerging technology trends, with coverage that overlaps DealForma's funding-rounds and company-profiles data for biopharma and adjacent verticals.
  • Crunchbase: Crunchbase is a broad startup and investment database covering funding rounds, M&A, and company information. It overlaps DealForma's venture-funding and company-profile data, particularly for biotech and digital health startups, though with less biopharma-specific curation.

Direct peers

  • BioCentury BCIQ: BCIQ is BioCentury's biopharma deal intelligence platform covering licensing, M&A, and venture financing — the closest direct competitor to DealForma. DealForma's pricing comparison page lists its minimum price at $20K vs BCIQ, indicating head-to-head competition for biopharma BD subscribers.
  • Evaluate Pharma: Evaluate Pharma provides consensus forecasts, deal data, and commercial intelligence for the pharma and biotech sector. It directly overlaps DealForma's drug sales figures and company profile offerings, targeting similar enterprise pharma BD users.

Emerging players

  • AlphaSense: AlphaSense is a market intelligence platform aggregating broker research, SEC filings, and transcripts for enterprise research workflows. It is listed alongside DealForma among top pharma market intelligence platforms and competes for similar enterprise research budgets with an AI-first search product.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

DealForma social profiles

Digital presence

DealForma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DealForma leadership team

Management profile

Number of profiles

Profiles2 records

DealForma funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DealForma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DealForma

What does DealForma do?

DealForma is a cloud-based SaaS biopharma deal intelligence platform that provides curated, analyst-vetted data on licensing deals, M&A transactions, venture funding, company profiles, drug pipelines, and drug sales figures for biotech and pharmaceutical companies. Subscriptions include interactive Tableau dashboards, natural language search, bundled analyst support, data export, and API access for site-licensed enterprise customers.

Is DealForma a public or private company?

DealForma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DealForma founded?

DealForma was founded in 2014. It employs 1 to 10 people.

Where is DealForma based?

DealForma is headquartered in San Mateo, United States, in the North America region.

How does DealForma make money?

One revenue line is on record: annual SaaS Subscription.

Who are DealForma's main competitors?

Broad incumbents on record are PitchBook Data, Cortellis (Clarivate), GlobalData, CB Insights and Crunchbase. Direct peers are BioCentury BCIQ and Evaluate Pharma. AlphaSense is listed as an emerging player.

Does DealForma have an API?

Yes. DealForma offers Data Feed/API capability for Site Licensed customers, allowing them to pipe DealForma data directly into their internal dashboards. The API enables programmatic access to deal data, funding information, company profiles, and drug sales figures.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals